This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Pt Dexa Medica. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovator Agung Heru Karsono: Pioneering Prostate Treatment Solutions
Introduction: Agung Heru Karsono, an inventive mind based in Jakarta Timur, Indonesia, has made significant strides in the field of medical innovations. As a dedicated inventor, he has contributed a valuable patent aimed at addressing crucial health issues related to prostate conditions.
Latest Patents: Agung holds an impactful patent titled "Val. et Zipp. Extract as a Treatment to Overcome Prostate Problems." This preparation includes a herbal extract and/or fraction, which has demonstrated bioactivities in reducing the expression levels of 5-alpha-reductase-1, androgen receptor, and PI3 in prostate cancer cells. The primary application of this invention focuses on reducing prostate enlargement. Additionally, his innovation shows potential in treating prostate cancer, lung cancer, and other diseases associated with the GPCR pathway.
Career Highlights: Agung Heru Karsono is currently associated with Pt Dexa Medica, a prominent company in the pharmaceutical industry. His work at this organization underlines his commitment to developing effective health solutions and showcases his technological expertise in medicinal formulations.
Collaborations: Throughout his career, Agung has collaborated with talented professionals such as Asep Aripin and Olivia Mayasari. These partnerships have likely contributed to enriching his inventive processes and enhancing the overall quality of his innovations.
Conclusion: Agung Heru Karsono exemplifies the spirit of innovation in the medical field, particularly with his significant contributions to prostate health. With one patent under his belt, it is evident that his work has the potential to make a lasting impact on treatment protocols for prostate-related conditions and inspire further research in related areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile